AFP and neoplasm: Testing of AFP as a tumor marker in peripheral blood, ultrasonography, and contrast-enhanced CT or magnetic resonance imaging (MRI) of the abdomen were completed in follow-up visits which were performed every 2 months during the first 6 month and every half year thereafter.